$AQST
Aquestive Therapeutics, Inc.

2019 Q4 Form 10-Q Financial Statement

#000114036119019856 Filed on November 05, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q4
Revenue $16.42M $12.42M $16.82M
YoY Change -2.41% -6.4% 37.9%
Cost Of Revenue $6.792M $4.643M $4.790M
YoY Change 41.8% -16.94% -14.77%
Gross Profit $9.627M $7.775M $12.04M
YoY Change -20.04% 1.24% 82.98%
Gross Profit Margin 58.63% 62.61% 71.56%
Selling, General & Admin $16.47M $13.71M $18.70M
YoY Change -11.93% 11.08% 147.03%
% of Gross Profit 171.08% 176.39% 155.32%
Research & Development $3.060M $5.063M $5.680M
YoY Change -46.13% 11.67% -9.41%
% of Gross Profit 31.79% 65.12% 47.18%
Depreciation & Amortization $770.0K $695.0K $760.0K
YoY Change 1.32% -5.18% -20.83%
% of Gross Profit 8.0% 8.94% 6.31%
Operating Expenses $26.32M $23.42M $29.17M
YoY Change -9.77% 4.22% 110.94%
Operating Profit -$16.70M -$11.00M -$17.13M
YoY Change -2.55% 19.52% 136.32%
Interest Expense -$2.730M $2.652M -$1.590M
YoY Change 71.7% 37.2% -42.81%
% of Operating Profit
Other Income/Expense, Net -$10.00K
YoY Change
Pretax Income -$12.64M -$18.41M -$13.94M
YoY Change -9.33% 22.44% 38.84%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$12.64M -$18.41M -$13.94M
YoY Change -9.38% 22.44% 38.88%
Net Earnings / Revenue -76.96% -148.27% -82.88%
Basic Earnings Per Share -$0.74
Diluted Earnings Per Share -$477.9K -$735.5K -$559.8K
COMMON SHARES
Basic Shares Outstanding 25.04M 25.03M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.33M $20.91M $60.60M
YoY Change -18.6% -67.32%
Cash & Equivalents $49.33M $20.91M $60.60M
Short-Term Investments
Other Short-Term Assets $3.000M $2.710M $1.680M
YoY Change 78.57% 88.19%
Inventory $2.859M $4.124M $5.441M
Prepaid Expenses
Receivables $13.13M $10.23M $6.450M
Other Receivables $0.00 $90.00K $30.00K
Total Short-Term Assets $68.31M $38.06M $74.20M
YoY Change -7.93% -50.8%
LONG-TERM ASSETS
Property, Plant & Equipment $9.726M $10.35M $12.21M
YoY Change -20.32% -15.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $286.0K $242.0K $239.0K
YoY Change 19.67% 10.0%
Total Long-Term Assets $10.17M $10.76M $12.65M
YoY Change -19.64% -14.96%
TOTAL ASSETS
Total Short-Term Assets $68.31M $38.06M $74.20M
Total Long-Term Assets $10.17M $10.76M $12.65M
Total Assets $78.48M $48.82M $86.85M
YoY Change -9.64% -45.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.27M $14.20M $20.44M
YoY Change -39.94% 15.09%
Accrued Expenses $5.475M $4.830M $7.195M
YoY Change -23.91% -7.12%
Deferred Revenue $806.0K $835.0K $721.0K
YoY Change 11.79%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $4.600M
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $18.56M $20.05M $32.95M
YoY Change -43.69% -5.99%
LONG-TERM LIABILITIES
Long-Term Debt $60.34M $59.78M $42.60M
YoY Change 41.64% 35.71%
Other Long-Term Liabilities $1.360M $3.450M $1.220M
YoY Change 11.48% 192.37%
Total Long-Term Liabilities $1.360M $63.23M $43.82M
YoY Change -96.9% 39.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.56M $20.05M $32.95M
Total Long-Term Liabilities $1.360M $63.23M $43.82M
Total Liabilities $84.60M $83.28M $76.77M
YoY Change 10.2% 25.1%
SHAREHOLDERS EQUITY
Retained Earnings -$130.5M -$117.8M -$61.38M
YoY Change 112.58%
Common Stock $34.00K $25.00K $25.00K
YoY Change 36.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.122M -$34.46M $10.08M
YoY Change
Total Liabilities & Shareholders Equity $78.48M $48.82M $86.85M
YoY Change -9.64% -45.76%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q4
OPERATING ACTIVITIES
Net Income -$12.64M -$18.41M -$13.94M
YoY Change -9.38% 22.44% 38.88%
Depreciation, Depletion And Amortization $770.0K $695.0K $760.0K
YoY Change 1.32% -5.18% -20.83%
Cash From Operating Activities -$10.57M -$14.79M -$2.810M
YoY Change 276.16% 28.83% -62.08%
INVESTING ACTIVITIES
Capital Expenditures -$80.00K -$90.00K -$490.0K
YoY Change -83.67% -79.55% 444.44%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$80.00K -$90.00K -$490.0K
YoY Change -83.67% -79.55% 444.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $37.30M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 39.07M 13.63M -80.00K
YoY Change -48937.5% -79.12% -85.96%
NET CHANGE
Cash From Operating Activities -10.57M -14.79M -2.810M
Cash From Investing Activities -80.00K -90.00K -490.0K
Cash From Financing Activities 39.07M 13.63M -80.00K
Net Change In Cash 28.42M -1.250M -3.380M
YoY Change -940.83% -102.34% -58.12%
FREE CASH FLOW
Cash From Operating Activities -$10.57M -$14.79M -$2.810M
Capital Expenditures -$80.00K -$90.00K -$490.0K
Free Cash Flow -$10.49M -$14.70M -$2.320M
YoY Change 352.16% 33.15% -68.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 aqst Inventory Packing Material Gross
InventoryPackingMaterialGross
2975000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Aquestive Therapeutics, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001398733
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25042964
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
20436000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
14202000
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
19218000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
27631000
CY2019Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
9687000
CY2018Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
6610000
CY2018Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2515000
CY2019Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
49000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1338000
CY2018Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
481000
CY2019Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1057000
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37333000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35191000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
889000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1297000
us-gaap Interest And Other Income
InterestAndOtherIncome
565000
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
83354000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
71431000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15038000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-47432000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
5230000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1422000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
995000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1810000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1739000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1870000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5200000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28541000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1236000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
58000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
94000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
55000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
50000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
39000
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13000
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13000
CY2018Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
1216000
CY2019Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
1322000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
106000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
102000
CY2019Q3 us-gaap Assets
Assets
48818000
CY2018Q4 us-gaap Assets
Assets
86851000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
74201000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
38060000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53610000
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Note 2.</td><td style="width: auto; vertical-align: top;"><div style="color: #000000; font-weight: bold;">Basis of Presentation</div></td></tr></table><div><br /></div><div style="color: #000000;">The accompanying interim unaudited condensed consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2018 included in our Annual Report on Form 10-K filed with the SEC on March 14, 2019 (the &#8220;2018 Annual Report on Form 10-K&#8221;). As included herein, the condensed consolidated balance sheet at December 31, 2018 is derived from the audited consolidated financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of the results of interim periods have been included. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited condensed financial statements.</div><div><br /></div><div style="color: #000000;">Any reference in these notes to applicable guidance refers to the authoritative U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</div></div>
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
46603000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-39685000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60599000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17379000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20914000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63982000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20914000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60599000
CY2019Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2000000
CY2019Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24957309
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25042964
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25042964
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24957309
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
25000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
25000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18412000
CY2019Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2127000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3762000
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2962000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1079000
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
835000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
721000
CY2019Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
760000
CY2018Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
284000
CY2019Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
0
CY2018Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2797000
us-gaap Depreciation
Depreciation
2143000
us-gaap Depreciation
Depreciation
2438000
CY2019Q3 us-gaap Depreciation
Depreciation
695000
CY2018Q3 us-gaap Depreciation
Depreciation
733000
us-gaap Paid In Kind Interest
PaidInKindInterest
0
aqst Number Of Patents
NumberOfPatents
2
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.15
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.64
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.45
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.45
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.15
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3480000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3604000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2019Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5278000
CY2018Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4116000
CY2019Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2867000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2867000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
204000
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
165000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
50000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2663000
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2702000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
50000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
50000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
50000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4896000
CY2018Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4896000
CY2018Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
216000
us-gaap Interest And Other Income
InterestAndOtherIncome
238000
us-gaap Paid In Kind Interest
PaidInKindInterest
24000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3887000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1291000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-566000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-591000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2754000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5632000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1317000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
469000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1029000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47432000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15038000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53610000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18412000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
138000
CY2018Q3 us-gaap Interest Expense
InterestExpense
1933000
us-gaap Interest Expense
InterestExpense
5809000
CY2019Q3 us-gaap Interest Expense
InterestExpense
2652000
us-gaap Interest Expense
InterestExpense
6515000
us-gaap Interest Paid Net
InterestPaidNet
5153000
us-gaap Interest Paid Net
InterestPaidNet
4511000
CY2019Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1253000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1183000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1283000
CY2019Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1142000
CY2019Q3 us-gaap Inventory Net
InventoryNet
4124000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-20472000
CY2018Q4 us-gaap Inventory Net
InventoryNet
5441000
CY2018Q4 us-gaap Liabilities
Liabilities
76771000
CY2019Q3 us-gaap Liabilities
Liabilities
83277000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48818000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86851000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32952000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
20053000
CY2018Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4600000
CY2019Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
70000000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
10500000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3500000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
17500000
CY2018Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
42603000
CY2019Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
59775000
CY2013Q3 us-gaap Loss Contingency Number Of Defendants
LossContingencyNumberOfDefendants
6
us-gaap Loss Contingency Claims Settled Number
LossContingencyClaimsSettledNumber
3
us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
4
CY2019Q3 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
2
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49635000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10179000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-577000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1334000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10527000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58116000
us-gaap Net Income Loss
NetIncomeLoss
-47432000
us-gaap Net Income Loss
NetIncomeLoss
-53610000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-15038000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-18412000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
4099000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-14726000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-36493000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1170000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
998000
CY2019Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
399000
CY2018Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
375000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
22472000
us-gaap Operating Expenses
OperatingExpenses
87189000
us-gaap Operating Expenses
OperatingExpenses
78954000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
23420000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9205000
CY2018Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
63482000
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
47684000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
47398000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
2944000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2723000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5903000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
0
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
3918000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4695000
us-gaap Operating Income Loss
OperatingIncomeLoss
-36583000
us-gaap Operating Income Loss
OperatingIncomeLoss
-42764000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11002000
CY2018Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
33000
CY2019Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
843000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
239000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
242000
us-gaap Other Noncash Expense
OtherNoncashExpense
16000
us-gaap Other Noncash Expense
OtherNoncashExpense
0
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
184000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
207000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
577000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1334000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1680000
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2706000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
112000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
0
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
70000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
68714000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5063000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17517000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10351000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12207000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
36000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
53000
us-gaap Repayments Of Debt
RepaymentsOfDebt
50000000
us-gaap Repayments Of Debt
RepaymentsOfDebt
0
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4534000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17429000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117838000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61376000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36190000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13267000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12418000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50606000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13714000
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12346000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47868000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53559000
us-gaap Share Based Compensation
ShareBasedCompensation
28541000
us-gaap Share Based Compensation
ShareBasedCompensation
5199000
CY2019Q3 us-gaap Share Price
SharePrice
15.00
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
132000
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
68714000
CY2018Q2 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
19934000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-34459000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
10080000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-38948000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-26495000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-24657000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-6056000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-22396000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
23444000
CY2018Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.08
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
388000
CY2019Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
246000
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="color: #000000; font-style: italic; font-weight: bold;">(B) Use of Estimates</div><div><br /></div><div style="color: #000000;">The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&#160; <font style="background-color: #FFFFFF;">Significant items subject to estimates and assumptions include allowances for rebates from proprietary product sales, the allowance for sales returns, the useful lives of fixed assets, valuation of warrants issued in connection with the 12.5% Senior Secured Notes, valuation of share-based compensation, and contingencies.</font></div></div>
CY2017Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
7673000
CY2018Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19335541
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23646192
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24992229
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25031478
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19335541
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25031478
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23646192
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24992229
CY2019Q3 aqst Long Term Debt Maturities Repayments Of Principal In Year Six And Thereafter
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSixAndThereafter
38500000
CY2019Q3 aqst Inventory Packing Material Gross
InventoryPackingMaterialGross
1729000
aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
16201000
aqst Warrants Issued In Connection With Long Term Debt
WarrantsIssuedInConnectionWithLongTermDebt
6800000
aqst Warrants Issued In Connection With Long Term Debt
WarrantsIssuedInConnectionWithLongTermDebt
0
aqst Deferred Financing Costs Charged To Additional Paid In Capital
DeferredFinancingCostsChargedToAdditionalPaidInCapital
0
aqst Deferred Financing Costs Charged To Additional Paid In Capital
DeferredFinancingCostsChargedToAdditionalPaidInCapital
5230000
aqst Payments Related To Tax Withholding For Share Based Compensation Accrued
PaymentsRelatedToTaxWithholdingForShareBasedCompensationAccrued
1701000
aqst Payments Related To Tax Withholding For Share Based Compensation Accrued
PaymentsRelatedToTaxWithholdingForShareBasedCompensationAccrued
0
CY2019Q3 aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
4643000
CY2019Q3 aqst Remaining Proceeds After Repayment Of Debt
RemainingProceedsAfterRepaymentOfDebt
13990000
CY2019Q3 aqst Number Of States In The Antitrust Litigation
NumberOfStatesInTheAntitrustLitigation
41
CY2019Q3 aqst Adjustments To Additional Paid In Capital Fair Value Of Warrants Issued
AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued
6800000
aqst Warrant Liability Reclassified To Equity
WarrantLiabilityReclassifiedToEquity
12951000
aqst Increase Decrease In Offering Costs Included In Accounts Payable And Accrued Expenses
IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
162000
aqst Increase Decrease In Offering Costs Included In Accounts Payable And Accrued Expenses
IncreaseDecreaseInOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
-515000
aqst Increase Decrease In Capital Expenditures Included In Accounts Payable And Accrued Expenses
IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses
-145000
aqst Increase Decrease In Capital Expenditures Included In Accounts Payable And Accrued Expenses
IncreaseDecreaseInCapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses
-290000
aqst Provision For Doubtful Accounts And Allowance For Doubtful Accounts Receivable Write Offs
ProvisionForDoubtfulAccountsAndAllowanceForDoubtfulAccountsReceivableWriteOffs
36000
aqst Provision For Doubtful Accounts And Allowance For Doubtful Accounts Receivable Write Offs
ProvisionForDoubtfulAccountsAndAllowanceForDoubtfulAccountsReceivableWriteOffs
20000
aqst Noncash Exercise Of Warrants
NoncashExerciseOfWarrants
0
aqst Noncash Exercise Of Warrants
NoncashExerciseOfWarrants
12591000
aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
13569000
CY2018Q3 aqst Manufacture And Supply Costs
ManufactureAndSupplyCosts
5592000
CY2018Q4 aqst Accruals For Wholesaler Fees Co Pay Cards And Rebates
AccrualsForWholesalerFeesCoPayCardsAndRebates
481000
CY2019Q3 aqst Accruals For Wholesaler Fees Co Pay Cards And Rebates
AccrualsForWholesalerFeesCoPayCardsAndRebates
1057000
aqst Accounts Receivable Allowances Provision Related To Sales
AccountsReceivableAllowancesProvisionRelatedToSales
1576000
aqst Accounts Receivable Allowances Credits And Payments
AccountsReceivableAllowancesCreditsAndPayments
984000
CY2018Q4 aqst Accounts Receivable Allowances And Accruals
AccountsReceivableAllowancesAndAccruals
585000
CY2019Q3 aqst Accounts Receivable Allowances And Accruals
AccountsReceivableAllowancesAndAccruals
1177000
CY2018Q4 aqst Accruals For Returns Allowances And Prompt Pay Discounts
AccrualsForReturnsAllowancesAndPromptPayDiscounts
104000
CY2019Q3 aqst Accruals For Returns Allowances And Prompt Pay Discounts
AccrualsForReturnsAllowancesAndPromptPayDiscounts
120000
CY2018Q4 aqst Accounts Receivable Allowances And Accruals Trade And Other Receivables Net
AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet
104000
CY2019Q3 aqst Accounts Receivable Allowances And Accruals Trade And Other Receivables Net
AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet
120000
CY2019Q3 aqst Trade And Other Receivables Net
TradeAndOtherReceivablesNet
10316000
CY2018Q4 aqst Trade And Other Receivables Net
TradeAndOtherReceivablesNet
6481000
aqst Invoices Payable Term
InvoicesPayableTerm
P105D
CY2019Q3 aqst Net Proceeds From Issuance Of Initial Notes Warrants And First Offer Rights
NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights
66082000
CY2019Q3 aqst Working Capital Deficit
WorkingCapitalDeficit
18007000
CY2018Q3 aqst Adjustments To Additional Paid In Capital Reclassification Of Warrant Liability To Equity
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiabilityToEquity
12951000
CY2018Q1 aqst Stock Issued During Period Values Stock Splits
StockIssuedDuringPeriodValuesStockSplits
0

Files In Submission

Name View Source Status
0001140361-19-019856-index-headers.html Edgar Link pending
0001140361-19-019856-index.html Edgar Link pending
0001140361-19-019856.txt Edgar Link pending
0001140361-19-019856-xbrl.zip Edgar Link pending
aqst-20190930.xml Edgar Link completed
aqst-20190930.xsd Edgar Link pending
aqst-20190930_cal.xml Edgar Link unprocessable
aqst-20190930_def.xml Edgar Link unprocessable
aqst-20190930_lab.xml Edgar Link unprocessable
aqst-20190930_pre.xml Edgar Link unprocessable
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending